Sign inJoin waitlistJoin the waitlist

Timothy Garrington

Pediatrics / Pediatric Hematology-Oncology · University Physicians Incorporated

Credentials: · ·

History

University of Colorado School of Medicine
1994–1997
Internal Medicine
1991–1994
University of Florida College of Medicine
1987–1991

Research

Organization and regulation of mitogen-activated protein kinase signaling pathways
Review · Current Opinion in Cell Biology · 1999 · First of 2 authors · Corresponding · 1,058 citations
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
New England Journal of Medicine · 2020 · 440 citations
Reovirus-induced apoptosis is mediated by TRAIL
Journal of Virology · 2000 · 171 citations

Brian Greffe
13 papers
CC
Carrye Cost
12 papers
Masanori Hayashi
6 papers
Nicholas Cost
6 papers
AL
Arthur Liu
5 papers
EG
Erwin Gelfand
5 papers
JB
Jennifer Bruny
5 papers
Margaret Macy
5 papers · 1 as a fellow
Nathan Donaldson
5 papers
Jennifer Black
4 papers
Arya Amini
3 papers · 3 as a resident
David Partrick
3 papers

Grants

Promoting Healthy Cancer Survivorship in Rural Colorado Primary Health Care Pract
National Cancer Institute · R25
PI · $1.5M · University of Colorado Denver
2012–2019
mekk2 Ko Defines Hematopoietic Cell Signal Function
National Cancer Institute · K08
Contact PI · $672.3K · University of Colorado Denver
2000–2006

Clinical trials

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2028
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Site PI · Recruiting · Phase 2
Children's Oncology Group
2020–2027
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Site PI · Recruiting · Phase 3
Children's Oncology Group
2017–2027